NIH-funded research R01 grant

Understanding how the measles vaccine affects the immune system

Official title: Immunological and Physiological Responses to Measles Vaccine

Funded at Johns Hopkins University · NIH-11012298 · Data updated 2026-11-12

This study is looking at how the measles vaccine works in kids under 11, focusing on how it helps their immune system fight off infections and stay healthy.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startJanuary 17, 2024
Project endNovember 30, 2028
Funding year2025
Award (this year)$767,262
NIH project number5R01AI182066-02
Project IDNIH-11012298 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation are children aged 0-11 years who are receiving or have received the measles vaccine.

Less likely to help

Patients who are older than 11 years or who have not received the measles vaccine may not benefit from this research.

What this research studies

This research investigates the immune and physiological responses to the measles vaccine, particularly in children under 11 years old. It aims to understand how the live attenuated measles vaccine (LAMV) interacts with the immune system, including the production of antibodies and the activation of immune cells. By studying both children and a rhesus macaque model, the research will explore the long-term effects of the vaccine on immunity and its potential role in preventing other infections. The findings could provide insights into improving vaccination strategies and understanding immune responses.

Why it matters

Potential benefit: If successful, this research could enhance the effectiveness of measles vaccination and improve overall child health by reducing mortality and morbidity associated with measles and other infections.

How similar studies have gone: Previous research has shown success in understanding immune responses to vaccines, making this approach both relevant and promising.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Pekosz, Andrew S. — Johns Hopkins University
  • Study coordinator: Pekosz, Andrew S.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.